Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cresnon vs Crestor in Hyperlipidemia
NCT02280590Phase 4Completed
- Sponsor
- Dong-A ST
- Start
- Sep 2014
- Primary completion
- Jun 2015
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in hyperlipidemia (2 arms), sponsored by Dong-A ST. Primary endpoint: The percent change in LDL-C at 8 weeks. Started Sep 2014; status: completed.
02
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT02280590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280590.